| Mrs Ann Palagi-pate, CNM, WHNP-BC | |
|
1201 S Main St, Fort Worth, TX 76104-4804 | |
| (817) 702-6540 | |
| Not Available |
| Full Name | Mrs Ann Palagi-pate |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1201 S Main St, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588076483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 734129 (Texas) | Secondary |
| 363LW0102X | Nurse Practitioner - Women's Health | 734129 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acclaim Physician Group Inc | 4587963582 | 439 |
News Archive
Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).
Most of us have had a doctor prescribe an antibiotic for a stubborn bacterial infection, or for a cut that gets infected. However, prescribing an antibiotic to fight cancer? In fact, anti-cancer antibiotics have been used since the 1950s to successfully treat several forms of cancer, but often the side effects limit the duration they can be given to a patient.
In the largest study of its kind to date, researchers analyzing national data from more than 63,000 patients with cancer and a positive COVID-19 diagnosis report an increased risk of death among those who were older, male, had a higher number of comorbidities, and had hematologic cancers and recent chemotherapy treatments.
Epocrates, Inc., today announced its top-ranked clinical reference application for the iPhone® and iPod® touch devices will be customized for the new iPad™ computer tablet. The iPad is already receiving a warm reception from the healthcare industry with nearly 20 percent of clinicians expressing plans to purchase in an Epocrates survey conducted days after the Apple announcement.
Actavis plc (NYSE: ACT) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Actavis' New Drug Application (NDA) resubmission for its atypical antipsychotic cariprazine, a potent dopamine D3/D2 receptor partial agonist with preferential binding to D3 receptors.
› Verified 4 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).
Most of us have had a doctor prescribe an antibiotic for a stubborn bacterial infection, or for a cut that gets infected. However, prescribing an antibiotic to fight cancer? In fact, anti-cancer antibiotics have been used since the 1950s to successfully treat several forms of cancer, but often the side effects limit the duration they can be given to a patient.
In the largest study of its kind to date, researchers analyzing national data from more than 63,000 patients with cancer and a positive COVID-19 diagnosis report an increased risk of death among those who were older, male, had a higher number of comorbidities, and had hematologic cancers and recent chemotherapy treatments.
Epocrates, Inc., today announced its top-ranked clinical reference application for the iPhone® and iPod® touch devices will be customized for the new iPad™ computer tablet. The iPad is already receiving a warm reception from the healthcare industry with nearly 20 percent of clinicians expressing plans to purchase in an Epocrates survey conducted days after the Apple announcement.
Actavis plc (NYSE: ACT) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Actavis' New Drug Application (NDA) resubmission for its atypical antipsychotic cariprazine, a potent dopamine D3/D2 receptor partial agonist with preferential binding to D3 receptors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ann Palagi-pate, CNM, WHNP-BC 1201 S Main St, Fort Worth, TX 76104-4804 Ph: (817) 702-6540 | Mrs Ann Palagi-pate, CNM, WHNP-BC 1201 S Main St, Fort Worth, TX 76104-4804 Ph: (817) 702-6540 |
News Archive
Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).
Most of us have had a doctor prescribe an antibiotic for a stubborn bacterial infection, or for a cut that gets infected. However, prescribing an antibiotic to fight cancer? In fact, anti-cancer antibiotics have been used since the 1950s to successfully treat several forms of cancer, but often the side effects limit the duration they can be given to a patient.
In the largest study of its kind to date, researchers analyzing national data from more than 63,000 patients with cancer and a positive COVID-19 diagnosis report an increased risk of death among those who were older, male, had a higher number of comorbidities, and had hematologic cancers and recent chemotherapy treatments.
Epocrates, Inc., today announced its top-ranked clinical reference application for the iPhone® and iPod® touch devices will be customized for the new iPad™ computer tablet. The iPad is already receiving a warm reception from the healthcare industry with nearly 20 percent of clinicians expressing plans to purchase in an Epocrates survey conducted days after the Apple announcement.
Actavis plc (NYSE: ACT) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Actavis' New Drug Application (NDA) resubmission for its atypical antipsychotic cariprazine, a potent dopamine D3/D2 receptor partial agonist with preferential binding to D3 receptors.
› Verified 4 days ago
Mrs. Amy Michelle Medalie, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4405 River Oaks Blvd, Fort Worth, TX 76114 Phone: 817-624-1770 Fax: 817-625-1287 | |
Valerie Elise Ward, RN, CPNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2755 Miller Ave, Fort Worth, TX 76105 Phone: 817-534-7110 Fax: 817-413-0521 | |
Maria Sybil Gagliano, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6000 Bryant Irvin Rd, Fort Worth, TX 76132 Phone: 866-389-2727 | |
Kristi E Tucker, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 | |
Lacy Pitchford, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1263 W Rosedale St Ste 200, Fort Worth, TX 76104 Phone: 817-336-4896 Fax: 817-332-2805 | |
Mary Agnes Johnson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave, Fort Worth, TX 76104 Phone: 817-922-7070 | |
Susan Akberzie, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1401 W Pulaski St, Fort Worth, TX 76104 Phone: 682-885-8012 Fax: 682-885-8014 |